✦ LIBER ✦

Pharmacokinetic aspects of palinavir, an HIV protease inhibitor, in Sprague–Dawley rats

✍ Scribed by Francine Liard; Jorge Jaramillo; William L. Paris; Christiane Yoakim

Book ID: 109388963
Publisher: John Wiley and Sons
Year: 1998
Tongue: English
Weight: 68 KB
Volume: 87
Category: Article
ISSN: 0022-3549
DOI: 10.1021/js970375r

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

In-vitro and in-vivo pharmacokinetic int

In-vitro and in-vivo pharmacokinetic interactions of amprenavir, an HIV protease inhibitor, with other current HIV protease inhibitors in rats

✍ Nobuhito Shibata; Weihua Gao; Hiroyuki Okamoto; Tomoyuki Kishida; Yukako Yoshika 📂 Article 📅 2002 🏛 Pharmaceutical Press 🌐 English ⚖ 226 KB

Pharmacokinetic and pharmacodynamic eval

Pharmacokinetic and pharmacodynamic evaluation of orally available hydroxyethylamine-derived beta-secretase inhibitors in Sprague Dawley rats

✍ Stephen Wood; Paul Wen; Patricia Amarante; Paul Acton; Jodi Bradley; Safura Babu 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 97 KB

Pharmacokinetic Interactions between HIV

Pharmacokinetic Interactions between HIV-1 Protease Inhibitors in Rats: Study on Combinations of Two Kinds of HIV-1 Protease Inhibitors

✍ NOBUHITO SHIBATA; YASUHIRO MATSUMURA; HIROYUKI OKAMOTO; YUKO KAWAGUCHI; AKIKO OH 📂 Article 📅 2000 🏛 Pharmaceutical Press 🌐 English ⚖ 113 KB

Pharmacokinetic and pharmacodynamic prof

Pharmacokinetic and pharmacodynamic profiles of the novel serotonin and norepinephrine reuptake inhibitor desvenlafaxine succinate in ovariectomized Sprague–Dawley rats

✍ Peter D. Alfinito; Christine Huselton; Xiaohong Chen; Darlene C. Deecher 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 191 KB

A pharmacokinetic evaluation of HIV prot

A pharmacokinetic evaluation of HIV protease inhibitors, cyclic ureas, in rats and dogs

✍ Y. Nancy Wong; Deborah L. Burcham; Philip L. Saxton; Susan Erickson-Viitanen; Ma 📂 Article 📅 1994 🏛 John Wiley and Sons 🌐 English ⚖ 425 KB 👁 2 views

## Abstract The pharmacokinetics of a series of novel cyclic, non‐peptide inhibitors of HIV protease were studied in rats or dogs after intravenous and oral administration. Six symmetrically substituted cyclic urea compounds (XK234, XM311, XM320, XM321, XM323, and XM412), which effectively inhibite

Phospholipid prodrug inhibitors of the H

Phospholipid prodrug inhibitors of the HIV protease: Antiviral activity and pharmacokinetics in rats

✍ Karl Y. Hostetler; Douglas D. Richman; Eric A. Forssen; Linda Selk; Rathna Basav 📂 Article 📅 1994 🏛 Elsevier Science 🌐 English ⚖ 523 KB